2022

Articles

1 - 

., S. Gataullina, ., G. Galvani, ., S. Touchet, ., C. Nous, ., E. Lemaire, ., J. Laschet, ., C. Chiron, ., O. Dulac, ., E. Dossi, ., J.-D. Brion, ., S. Messaoudi, ., M. Alami, ., G. Huberfeld, .

Svetlana Gataullina, Gilles Galvani, Sabrina Touchet, Caroline Nous, Eric LemaireGluN2C selective inhibition is a target to develop new antiepileptic compounds. Epilepsia, 2022,

DOI : https://doi.org/10.1111/epi.17396